Anticholinergic Drugs and Risk of Cognitive Impairment and Dementia
The Carlat Hospital Psychiatry Report, Volume 1, Number 7&8, October 2021
Shelly L. Gray, PharmD
Professor and Plein Endowed Director, Plein Center for Geriatric Pharmacy Research, School of Pharmacy, University of Washington, Seattle, WA.
Dr. Gray has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.
Might anticholinergic medications increase the risk of long-term cognitive impairment? Dr. Gray reviews the data.